跳至主要内容
临床试验/CTRI/2020/11/029175
CTRI/2020/11/029175尚未招募未知

Role of Heparin Nebulization in Reducing Time of Mechanical ventilation in patients with SARS-CoV-2

AIIMS Patna0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Confirmed COVID-19, Endotracheal tube in place, Intubated the day before or same day, PaO2 to FIO2 ratio less than or equal to 300 while intubated, Acute opacities not fully explained by effusions, lobar/lung collapse and nodules, affecting at least one lung quadrant on chest X-ray or CT, Currently in the ICU or scheduled for transfer to the ICU.

排除标准

  • Enrolled in another clinical trial that is unapproved for co-enrolment, Heparin allergy or HIT, APTT > 120 seconds and this is not due to anticoagulant therapy, Platelet count < 20 x 109 per L, Pulmonary bleeding, which is frank bleeding in the trachea, bronchi or lungs with, Repeated haemoptysis or requiring repeated suctioning, Uncontrolled bleeding, Pregnant or might be pregnant, Myopathy, spinal cord injury, or nerve injury or disease with a likely prolonged incapacity to breathe independently e.g. Guillain-Barre syndrome, Usually receives home oxygen, Death is imminent or inevitable within 24 hours

研究者

发起方
AIIMS Patna

相似试验

Role of Heparin inhalation in reducing the duration... | 临床试验